Cellular and molecular mechanisms underlying the strong neonatal IL-12 response of lamb mesenteric lymph node cells to R-848.
BACKGROUND
Comparative studies on the response of neonates and adults to TLR stimulation have been almost exclusively limited to comparisons of human neonatal cord blood cells with peripheral blood from adults, and analyses of spleen cell responses in mice. We need to extend these studies and gain further information regarding such responses at mucosal sites.


RESULTS
We used sheep as a large animal model to study TLR agonist responses in the lymph nodes draining the intestine, an organ that must adapt to profound changes after birth. In response to the imidazoquinoline compound R-848, neonatal mesenteric lymph node (MLN) and spleen cells produced more IL-12 and, consequently, more IFNγ than their adult counterparts. This difference was age-related for both organs, but the preferential IL-12 response decreased more rapidly in the MLN, with young animals producing similar amounts of this cytokine to adults, from the age of 20 days onwards. Intracellular assays and depletion experiments identified CD14(+)CD11b(+)CD40(+) cells as the main producer of IL-12. These cells accounted for a greater proportion of neonatal than of adult MLN cells, and also produced, in direct response to R-848, more IL-12 after isolation. This strong IL-12 response in neonates occurred despite the production of larger amounts of the regulatory cytokine IL-10 and the stronger upregulation of SOCS-1 and SOCS-3 mRNA levels than in adult cells, and was correlated with an increase in p38/MAPK phosphorylation.


CONCLUSIONS
This is the first attempt to decipher the mechanism by which neonatal MLN cells produce more IL-12 than adult cells in response to the TLR8 agonist R-848. CD14(+)CD11b(+)CD40(+) IL-12-producing cells were more numerous in neonate than in adult MLN cells and displayed higher intracellular responsiveness upon R-848 stimulation. This work provides relevant information for future vaccination or immunostimulation strategies targeting neonates.
Equipe Contrôle et Immunologie des Maladies Entériques du Nouveau-Né, UR1282 Infectiologie Animale et Santé Publique, INRA Nouzilly, Nouzilly, France.
Stéphanie
S
Ferret-Bernard
Aude
A
Remot
Sonia
S
Lacroix-Lamandé
Coralie
C
Metton
Nelly
N
Bernardet
Françoise
F
Drouet
Fabrice
F
Laurent
D000818:Animals; D000831:Animals, Newborn; D015703:Antigens, CD / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D007093:Imidazoles / Q000494:pharmacology*; D007371:Interferon-gamma / Q000096:biosynthesis; D018664:Interleukin-12 / Q000096:biosynthesis*; D008198:Lymph Nodes / Q000166:cytology / Q000187:drug effects* / Q000276:immunology / Q000648:ultrastructure; D008643:Mesentery / Q000166:cytology*; D008854:Microscopy, Electron; D012756:Sheep; D051193:Toll-Like Receptors / Q000819:agonists
D015703:Antigens, CD; D007093:Imidazoles; D051193:Toll-Like Receptors; D018664:Interleukin-12; D007371:Interferon-gamma; C402365:resiquimod